173 related articles for article (PubMed ID: 34070369)
21. Anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia.
Sutherland MK; Yu C; Lewis TS; Miyamoto JB; Morris-Tilden CA; Jonas M; Sutherland J; Nesterova A; Gerber HP; Sievers EL; Grewal IS; Law CL
MAbs; 2009; 1(5):481-90. PubMed ID: 20065652
[TBL] [Abstract][Full Text] [Related]
22. Targeting folate receptor beta on monocytes/macrophages renders rapid inflammation resolution independent of root causes.
Lu YJ; Wheeler LW; Chu H; Kleindl PJ; Pugh M; You F; Rao S; Garcia G; Wu HY; da Cunha AP; Johnson R; Westrick E; Cross V; Lloyd A; Dircksen C; Klein PJ; Vlahov IR; Low PS; Leamon CP
Cell Rep Med; 2021 Oct; 2(10):100422. PubMed ID: 34755134
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of folate receptor β-expressing tumor-associated macrophages in pancreatic cancer.
Kurahara H; Takao S; Kuwahata T; Nagai T; Ding Q; Maeda K; Shinchi H; Mataki Y; Maemura K; Matsuyama T; Natsugoe S
Ann Surg Oncol; 2012 Jul; 19(7):2264-71. PubMed ID: 22350599
[TBL] [Abstract][Full Text] [Related]
24. Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients.
van der Heijden JW; Oerlemans R; Dijkmans BA; Qi H; van der Laken CJ; Lems WF; Jackman AL; Kraan MC; Tak PP; Ratnam M; Jansen G
Arthritis Rheum; 2009 Jan; 60(1):12-21. PubMed ID: 19116913
[TBL] [Abstract][Full Text] [Related]
25. The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells.
Estupina P; Fontayne A; Barret JM; Kersual N; Dubreuil O; Le Blay M; Pichard A; Jarlier M; Pugnière M; Chauvin M; Chardès T; Pouget JP; Deshayes E; Rossignol A; Abache T; de Romeuf C; Terrier A; Verhaeghe L; Gaucher C; Prost JF; Pèlegrin A; Navarro-Teulon I
Oncotarget; 2017 Jun; 8(23):37061-37079. PubMed ID: 28427157
[TBL] [Abstract][Full Text] [Related]
26. Design and Production An Effective Bispecific Tandem Chimeric Antigen Receptor on T Cells against CD123 and Folate Receptor ß towards B-Acute Myeloid Leukaemia Blasts.
Ghamari A; Pakzad P; Majd A; Ebrahimi M; Hamidieh AA
Cell J; 2021 Nov; 23(6):650-657. PubMed ID: 34939758
[TBL] [Abstract][Full Text] [Related]
27. CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy.
Rodriguez-Garcia A; Lynn RC; Poussin M; Eiva MA; Shaw LC; O'Connor RS; Minutolo NG; Casado-Medrano V; Lopez G; Matsuyama T; Powell DJ
Nat Commun; 2021 Feb; 12(1):877. PubMed ID: 33563975
[TBL] [Abstract][Full Text] [Related]
28.
Guo X; Mahlakõiv T; Ye Q; Somanchi S; He S; Rana H; DiFiglia A; Gleason J; van der Touw W; Hariri R; Zhang X
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33741730
[TBL] [Abstract][Full Text] [Related]
29. A Chemo-enzymatically Linked Bispecific Antibody Retargets T Cells to a Sialylated Epitope on CD43 in Acute Myeloid Leukemia.
Bartels L; de Jong G; Gillissen MA; Yasuda E; Kattler V; Bru C; Fatmawati C; van Hal-van Veen SE; Cercel MG; Moiset G; Bakker AQ; van Helden PM; Villaudy J; Hazenberg MD; Spits H; Wagner K
Cancer Res; 2019 Jul; 79(13):3372-3382. PubMed ID: 31064847
[TBL] [Abstract][Full Text] [Related]
30. Development of a novel fully-human anti-CD123 antibody to target acute myeloid leukemia.
Hutmacher C; Volta L; Rinaldi F; Murer P; Myburgh R; Manz MG; Neri D
Leuk Res; 2019 Sep; 84():106178. PubMed ID: 31326578
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia.
Caracciolo D; Riillo C; Ballerini A; Gaipa G; Lhermitte L; Rossi M; Botta C; Duroyon E; Grillone K; Gallo Cantafio ME; Buracchi C; Alampi G; Gulino A; Belmonte B; Conforti F; Golino G; Juli G; Altomare E; Polerà N; Scionti F; Arbitrio M; Iannone M; Martino M; Correale P; Talarico G; Ghelli Luserna di Rorà A; Ferrari A; Concolino D; Sestito S; Pensabene L; Giordano A; Hildinger M; Di Martino MT; Martinelli G; Tripodo C; Asnafi V; Biondi A; Tagliaferri P; Tassone P
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33597219
[TBL] [Abstract][Full Text] [Related]
32. In vivo efficacy of the recombinant anti-CD64 immunotoxin H22(scFv)-ETA' in a human acute myeloid leukemia xenograft tumor model.
Tur MK; Huhn M; Jost E; Thepen T; Brümmendorf TH; Barth S
Int J Cancer; 2011 Sep; 129(5):1277-82. PubMed ID: 21077160
[TBL] [Abstract][Full Text] [Related]
33. Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells.
Fatehchand K; McMichael EL; Reader BF; Fang H; Santhanam R; Gautam S; Elavazhagan S; Mehta P; Buteyn NJ; Merchand-Reyes G; Vasu S; Mo X; Benson DM; Blachly JS; Carson WE; Byrd JC; Butchar JP; Tridandapani S
J Biol Chem; 2016 Dec; 291(49):25656-25666. PubMed ID: 27780867
[TBL] [Abstract][Full Text] [Related]
34. AntiCD3Fv fused to human interleukin-3 deletion variant redirected T cells against human acute myeloid leukemic stem cells.
Fan D; Li Z; Zhang X; Yang Y; Yuan X; Zhang X; Yang M; Zhang Y; Xiong D
J Hematol Oncol; 2015 Feb; 8():18. PubMed ID: 25879549
[TBL] [Abstract][Full Text] [Related]
35. Smart Human-Serum-Albumin-As
Peng Y; Zhao Z; Liu T; Li X; Hu X; Wei X; Zhang X; Tan W
Angew Chem Int Ed Engl; 2017 Aug; 56(36):10845-10849. PubMed ID: 28686804
[TBL] [Abstract][Full Text] [Related]
36. Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T Cells.
Lee WS; Ye Z; Cheung AMS; Goh YPS; Oh HLJ; Rajarethinam R; Yeo SP; Soh MK; Chan EHL; Tan LK; Tan SY; Chuah C; Chng WJ; Connolly JE; Wang CI
Mol Cancer Ther; 2021 Sep; 20(9):1702-1712. PubMed ID: 34158344
[TBL] [Abstract][Full Text] [Related]
37. Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha.
Ebel W; Routhier EL; Foley B; Jacob S; McDonough JM; Patel RK; Turchin HA; Chao Q; Kline JB; Old LJ; Phillips MD; Nicolaides NC; Sass PM; Grasso L
Cancer Immun; 2007 Mar; 7():6. PubMed ID: 17346028
[TBL] [Abstract][Full Text] [Related]
38. Folate Receptor β Regulates Integrin CD11b/CD18 Adhesion of a Macrophage Subset to Collagen.
Machacek C; Supper V; Leksa V; Mitulovic G; Spittler A; Drbal K; Suchanek M; Ohradanova-Repic A; Stockinger H
J Immunol; 2016 Sep; 197(6):2229-38. PubMed ID: 27534550
[TBL] [Abstract][Full Text] [Related]
39. Depletion of folate receptor β-expressing macrophages alleviates bleomycin-induced experimental skin fibrosis.
Li H; Nagai T; Hasui K; Matsuyama T
Mod Rheumatol; 2014 Sep; 24(5):816-22. PubMed ID: 24498991
[TBL] [Abstract][Full Text] [Related]
40. 5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia.
Sutherland MK; Yu C; Anderson M; Zeng W; van Rooijen N; Sievers EL; Grewal IS; Law CL
MAbs; 2010; 2(4):440-8. PubMed ID: 20495353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
